CYCLOPHOSPHAMIDE
- Product NDC
- 50742-521
- 11-digit product format
- 507420521
- Labeler code
- 50742
- Product ID
- 50742-521_83db39e2-26c4-4971-9452-710144a389c3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cyclophosphamide
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Ingenus Pharmaceuticals, LLC
- Application
- NDA212501
- Marketing category
- NDA
- Marketing start
- 2021-09-16
- Marketing end
- 0000-00-00
- Substance
- CYCLOPHOSPHAMIDE ANHYDROUS
- Active strength
- 200 mg/mL
- Pharmacologic classes
- Alkylating Activity [MoA], Alkylating Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50742-521-10 | 50742052110 | 1 VIAL in 1 CARTON (50742-521-10) > 10 mL in 1 VIAL | 1 vial | 2021-09-16 | 0000-00-00 | No | No | Current |